Ann: Phase 1 Study Closure and Preliminary Performance, page-26

Their business model I believe

From developing and owning a totally new imaging specialist equipment using their own imagining nano particle agents (slow capital consuming development program)

to now

using existing MRI specialist equipment (owned by others) together with their own imaging nano particle agents (expedited low capital cost program)

I believe now it’s all about partnering using their nano particles

the key to me (and I have zero technical expertise in this matter) is that these nano particles are clearly seen to be attaching to tumours

to me that is HUGE, as there may be huge opportunity for treating malignant tumours without the devastating effects of the side effects from chemo

not withstanding the huge impact it may have on identifying malignant vs benign tumours

but direct acting molecules (as an alternative to chemo) could be attached to IBX’s nano particles that seem to be sticking to these tumours and treat the target directly

just thinking out loud really